Current Radiopharmaceuticals
Volume 14, 4 Issues, 2021
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Aims & Scope
Current Radiopharmaceuticals publishes original research articles, letters, full-length/mini reviews, drug clinical trial studies and guest edited issues on all aspects of research and development of radiolabelled compound preparations, covering studies related to nuclear medicine, molecular imaging, radionuclide therapy, as radiology, oncology and radiotherapy and basic research. The scope of the journal also covers the following areas: radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research and applications.
Current Radiopharmaceuticals
,Volume 13
-Number 3
Editorial Open Access
The Imaging of Lung Cancer: A Complete Vision
, 13(3): 165Luigi Mansi and Laura Evangelista
DOI: 10.2174/187447101303201029121009
The Imaging of Lung Cancer: A Complete Vision
Review Article Open Access
99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
, 13(3): 166 - 176Vittorio Briganti, Vincenzo Cuccurullo*, Valentina Berti, Giuseppe D. Di Stasio, Flavia Linguanti, Francesco Mungai and Luigi Mansi
DOI: 10.2174/1874471013666191230143610
99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
Review Article Open Access
PET/CT and the Response to Immunotherapy in Lung Cancer
, 13(3): 177 - 184Laura Evangelista*, Matteo Sepulcri and Giulia Pasello
DOI: 10.2174/1874471013666191220105449
PET/CT and the Response to Immunotherapy in Lung Cancer
Review Article
Alternative and New Radiopharmaceutical Agents for Lung Cancer
, 13(3): 185 - 194Silvi Telo*, Letizia Calderoni, Sara Vichi, Federico Zagni, Paolo Castellucci and Stefano Fanti
DOI: 10.2174/1874471013666191223151402
Alternative and New Radiopharmaceutical Agents for Lung Cancer
Review Article
FDG PET/CT in the Staging of Lung Cancer
, 13(3): 195 - 203Mohsen Farsad*
DOI: 10.2174/1874471013666191223153755
FDG PET/CT in the Staging of Lung Cancer
Review Article Open Access
Radiotherapy Planning and Molecular Imaging in Lung Cancer
, 13(3): 204 - 217Angelina Filice*, Massimiliano Casali, Patrizia Ciammella, Marco Galaverni, Federica Fioroni, Cinzia Iotti and Annibale Versari
DOI: 10.2174/1874471013666200318144154
Radiotherapy Planning and Molecular Imaging in Lung Cancer
Review Article Open Access
Respiratory Gating and the Performance of PET/CT in Pulmonary Lesions
, 13(3): 218 - 227Cinzia Crivellaro and Luca Guerra*
DOI: 10.2174/1874471013666200317144629
Respiratory Gating and the Performance of PET/CT in Pulmonary Lesions
Review Article Open Access
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art
, 13(3): 228 - 237Angelo Castello , Sabrina Rossi and Egesta Lopci *
DOI: 10.2174/1874471013666191230144821
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art
Articles Ahead of Print
Evaluation of Left Ventricular Volumes and Ejection Fraction from Gated Myocardial Perfusion SPECT Processed with “Myovation Evolution”: Comparison of Three Automated Software Packages using Cardiac Magnetic Resonance as Reference
Enrico Calandri*, Francesca Guana, Mirco Pultrone, Stefano Leuzzi, Giovanna Chiorino, Eleonora Soligo, Viviana Frantellizzi, Sonya Gallina, Mauro Liberatore and Giuseppe De Vincentis
DOI: 10.2174/1874471013666200915130100
View Abstract View on PubMed
Direct incorporation of [18F] into Aliphatic Systems: A promising Mn-catalysed Labelling Technique for PET Imaging
Sara Cesarec, Jonathan A. Robson, Laurence S. Carroll*, Eric O. Aboagye and Alan C. Spivey
DOI: 10.2174/1874471013666200907115026
View Abstract View on PubMed
GMP-Automated Purification of Copper-61 Produced in Cyclotron Liquid Targets: Methodological Aspects
Alexandra I. Fonseca, Vítor H. Alves, Sérgio J. C. do Carmo, Amílcar Falcão, Antero J. Abrunhosa and Francisco Alves*
DOI: 10.2174/1874471013666201112141844
View Abstract View on PubMed
90Y-DOTA-nimotuzumab: Synthesis of a Promising β⁻ radiopharmaceutical
Teresa Scotognella*, Daria Maccora, Isabella Bruno, Marco Chinol, Massimo Castagnola, Francesco Collamati, Carlo Mancini-Terraciano, Silvio Morganti, Valerio Bocci, Elena Solfaroli Camillocci, Dante Rotili, Antonella Cartoni, Ilaria Fratoddi, Federica Marini, Iole Venditti, Riccardo Faccini and Alessandro Giordano
DOI: 10.2174/1874471013999210104220031
View Abstract
Theranostic radiopharmaceuticals targeting cancer-associated fibroblasts
Fedor Zhuravlev*
DOI: 10.2174/1874471013666201224114148
View Abstract
A review of accelerator-produced Ga-68 with solid targets
Kaelyn V. Becker, Margarita Chernysheva, Todd E. Barnhart, Katherine Gagnon and Jonathan W. Engle*
DOI: 10.2174/1874471013666201224113651
View Abstract
New Therapies to Modulate Post-infarction Inflammatory Alterations in the Myocardium: State of the art and Forthcoming Applications
Olivier F. Clerc*, Philip Haaf, Ronny R Buechel, Oliver Gaemperli and Michael J. Zellweger
DOI: 10.2174/1874471013666201210140743
View Abstract
Analytical GC-FID Method for the Determination of Organic Solvents in Radiopharmaceuticals
Hishar Hassan, Muhammad Faiz Othman, Zainul Amiruddin Zakaria, Fathinul Fikri Ahmad Saad and Hairil Rashmizal Abdul Razak*
DOI: 10.2174/1874471013999201027215704
View Abstract View on PubMed
Development of 186/188Re-Chitosan as an Effective Therapeutic Agent for Rheumatoid Arthritis
Nahid Ahmadi, Hassan Yousefnia*, Ali Bahrami-Samani, Samaneh Zolghadri, Behrouz Alirezapour and Fatemeh Mohammadpour Ghazi
DOI: 10.2174/1874471013666201203152941
View Abstract
Calcium Carbonate Microparticles as Carriers of 224Ra: Impact of Specific Activity in Mice with Intraperitoneal Ovarian Cancer
Ruth Gong Li, Elisa Napoli, Ida Sofie Jorstad, Tina Bjørnlund Bønsdorff, Asta Juzeniene, Øyvind Sverre Bruland, Roy Hartvig Larsen and Sara Westrøm*
DOI: 10.2174/1874471013666201201102056
View Abstract
Abstracts Ahead of Print
There are currently no Abstracts Ahead of Print available for this journal.
Published Contents
- Current Radiopharmaceuticals, Volume 13, 2020
- Current Radiopharmaceuticals, Volume 12, 2019
- Current Radiopharmaceuticals, Volume 11, 2018
- Current Radiopharmaceuticals, Volume 10, 2017
- Current Radiopharmaceuticals, Volume 9, 2016
- Current Radiopharmaceuticals, Volume 8, 2015
- Current Radiopharmaceuticals, Volume 7, 2014
- Current Radiopharmaceuticals, Volume 6, 2013
- Current Radiopharmaceuticals, Volume 5, 2012
- Current Radiopharmaceuticals, Volume 4, 2011
- Current Radiopharmaceuticals, Volume 3, 2010
- Current Radiopharmaceuticals, Volume 2, 2009
- Current Radiopharmaceuticals, Volume 1, 2008
Editor's Choice
Radiotherapy Planning and Molecular Imaging in Lung Cancer
, 2020; 13(3): 204 - 217Angelina Filice*, Massimiliano Casali, Patrizia Ciammella, Marco Galaverni, Federica Fioroni, Cinzia Iotti and Annibale Versari
DOI: 10.2174/1874471013666200318144154
New 99mTc Radiotracers for Myocardial Perfusion Imaging by SPECT
, 2019; 12(3): 171 - 186Wei Fang* and Shuang Liu*
DOI: 10.2174/1874471012666190206102214
68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers
, 2019; 12(3): 238 - 246Ferdinando Calabria*, Robert Pichler, Mario Leporace, Johannes Wolfsgruber, Pierluigi Coscarelli, Andreas Dunzinger, Orazio Schillaci, Giuseppe Lucio Cascini and Antonio Bagnato
DOI: 10.2174/1874471012666190515090755
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours
, 2019; 12(2): 98 - 106Vincenzo Cuccurullo*, Giuseppe Danilo Di Stasio and Luigi Mansi
DOI: 10.2174/1874471012666190206094555
[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations
, 2019; 12(1): 58 - 71Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*
DOI: 10.2174/1874471012666190102165053
The Production of Ac-225
, 2018; 11(3): 173 - 179Jonathan W. Engle*
DOI: 10.2174/1874471011666180418141357
NorthStar Perspectives for Actinium-225 Production at Commercial Scale
, 2018; 11(3): 180 - 191James T. Harvey*
DOI: 10.2174/1874471011666180515123848
Ga-68 Nanoparticles and Ultra-small Nanoparticle: Next Generation of PET Radiopharmaceuticals?
, 2018; 11(2): 123 - 129Mohammed Al-Qahtani, Yousif Al Malki, Hadeel Mutwali, Edward Helal-Neto and Ralph Santos-Oliveira*
DOI: 10.2174/1874471011666180418110206
Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy
, 2018; 11(1): 34 - 45Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa
DOI: 10.2174/1874471011666171229123130
Personalized & Precision Medicine in Cancer: A Theranostic Approach
, 2017; 10(3): 166 - 170Partha Choudhury* and Manoj Gupta
DOI: 10.2174/1874471010666170728094008
Open Access Articles
The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy
, 2020; 13(3): 243 - 248Marco Spadafora*, Laura Evangelista, Salvatore Fiordoro, Francesco Porcaro, Marilena Sicignano and Luigi Mansi
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art
, 2020; 13(3): 228 - 237Angelo Castello , Sabrina Rossi and Egesta Lopci *
Respiratory Gating and the Performance of PET/CT in Pulmonary Lesions
, 2020; 13(3): 218 - 227Cinzia Crivellaro and Luca Guerra*
Radiotherapy Planning and Molecular Imaging in Lung Cancer
, 2020; 13(3): 204 - 217Angelina Filice*, Massimiliano Casali, Patrizia Ciammella, Marco Galaverni, Federica Fioroni, Cinzia Iotti and Annibale Versari
Alternative and New Radiopharmaceutical Agents for Lung Cancer
, 2020; 13(3): 185 - 194Silvi Telo*, Letizia Calderoni, Sara Vichi, Federico Zagni, Paolo Castellucci and Stefano Fanti
PET/CT and the Response to Immunotherapy in Lung Cancer
, 2020; 13(3): 177 - 184Laura Evangelista*, Matteo Sepulcri and Giulia Pasello
99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
, 2020; 13(3): 166 - 176Vittorio Briganti, Vincenzo Cuccurullo*, Valentina Berti, Giuseppe D. Di Stasio, Flavia Linguanti, Francesco Mungai and Luigi Mansi
Preparation and Biological Evaluation of 67Gallium- Labeled Iranian Hemiscorpius Lepturus Scorpion Venom
, 2020; 13(2): 99 - 106Amir Jalali*, Mona Haddad Zahmatkesh, Amir Reza Jalilian, Amir Taheri Borujeni and Behrouz Alirezapour
Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas
, 2020; 13(2): 94 - 98Francesco Bertagna*, Domenico Albano, Elisabetta Cerudelli, Maria Gazzilli, Raffaele Giubbini and Giorgio Treglia
Analysis of Unusual Adverse Effects After Radium-223 Dichloride Administration
, 2020; 13(2): 159 - 163Viviana Frantellizzi*, Mariano Pontico, Arianna Pani, Roberto Pani and Giuseppe De Vincentis
Analysis of Cell Fraction of 99mTc-HMPAO Radiolabeled Leukocytes
, 2020; 13(2): 142 - 148Eun-Mi Kim, Hwan-Jeong Jeong*, Seok-Tae Lim and Myung-Hee Sohn
In situ Generated 212Pb-PSMA Ligand in a 224Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells
, 2020; 13(2): 130 - 141Vilde Y. Stenberg, Asta Juzeniene*, Øyvind S. Bruland and Roy H. Larsen
Oxidant and Antioxidant Effects of Gentisic Acid in a 177Lu-Labelled Methionine-Containing Minigastrin Analogue
, 2020; 13(2): 107 - 119Victoria Trindade* and Henia Balter
Most Cited Articles
Systematic Review Article
Potential of radiolabeled PSMA PET/CT or PET/MRI diagnostic procedures in gliomas/glioblastomas
, 2020; 13(2): 94-98.Francesco Bertagna*, Domenico Albano, Elisabetta Cerudelli, Maria Gazzilli, Raffaele Giubbini and Giorgio Treglia
DOI: 10.2174/1874471012666191017093721
Review Article
Pet/ct and the response to immunotherapy in lung cancer
, 2020; 13(3): 177-184.Laura Evangelista*, Matteo Sepulcri and Giulia Pasello
DOI: 10.2174/1874471013666191220105449
Review Article
Alternative and new radiopharmaceutical agents for lung cancer
, 2020; 13(3): 185-194.Silvi Telo*, Letizia Calderoni, Sara Vichi, Federico Zagni, Paolo Castellucci and Stefano Fanti
DOI: 10.2174/1874471013666191223151402
Research Article
Clinical and prognostic value of<sup>18</sup>F-FDG-PET/CT in the restaging process of recurrent cutaneous melanoma
, 2020; 13(1): 42-47.Domenico Albano, Demetrio Familiari, Maria C. Fornito, Salvatore Scalisi, Riccardo Laudicella, Massimo Galia, Emanuele Grassedonio, Antonella Ruggeri, Gloria Ganduscio, Marco Messina, Massimiliano Spada, Massimo Midiri and Pierpaolo Alongi*
DOI: 10.2174/1874471012666191009161826
Review Article
Sentinel node identification in melanoma: Current clinical impact, new emerging SPECT radiotracers and technological advancements. an update of the last decade
, 2020; 13(1): 32-41.Natale Quartuccio*, Massimiliano Siracusa, Marco Pappalardo, Annachiara Arnone and Gaspare Arnone
DOI: 10.2174/1874471012666191015100837
Review Article
Evidence-based data about prevalence and risk of malignancy of thyroid incidentalomas detected by different PET radiopharmaceuticals
, 2020; 13(2): 89-93.Giovanni Signore, Domenico Albano, Luca Giovanella, Francesco Bertagna and Giorgio Treglia*
DOI: 10.2174/1874471012666191212115732
Research Article
The multicenter italian trial assesses the performance of FDG-PET/CT related to pre-test cancer risk in patients with solitary pulmonary nodules and introduces a segmental thoracic diagnostic strategy
, 2020; 13(3): 243-248.Marco Spadafora*, Laura Evangelista, Salvatore Fiordoro, Francesco Porcaro, Marilena Sicignano and Luigi Mansi
DOI: 10.2174/1874471013666200318142210
Review Article
Respiratory gating and the performance of pet/ct in pulmonary lesions
, 2020; 13(3): 218-227.Cinzia Crivellaro and Luca Guerra*
DOI: 10.2174/1874471013666200317144629
Review Article
18f-fdg pet/ct in restaging and evaluation of response to therapy in lung cancer: State of the art
, 2020; 13(3): 228-237.Angelo Castello , Sabrina Rossi and Egesta Lopci *
DOI: 10.2174/1874471013666191230144821
Review Article
Lung cancer and radiological imaging
, 2020; 13(3): 238-242.Annalori Panunzio* and Paolo Sartori
DOI: 10.2174/1874471013666200523161849
Review Article
FDG PET/CT in the staging of lung cancer
, 2020; 13(3): 195-203.Mohsen Farsad*
DOI: 10.2174/1874471013666191223153755
Review Article
99mtc-edda/hynic-toc is a new opportunity in neuroendocrine tumors of the lung (And in other malignant and benign pulmonary diseases)
, 2020; 13(3): 166-176.Vittorio Briganti, Vincenzo Cuccurullo*, Valentina Berti, Giuseppe D. Di Stasio, Flavia Linguanti, Francesco Mungai and Luigi Mansi
DOI: 10.2174/1874471013666191230143610
Review Article
Radiotherapy planning and molecular imaging in lung cancer
, 2020; 13(3): 204-217.Angelina Filice*, Massimiliano Casali, Patrizia Ciammella, Marco Galaverni, Federica Fioroni, Cinzia Iotti and Annibale Versari
DOI: 10.2174/1874471013666200318144154
Case Report
Analysis of unusual adverse effects after radium-223 dichloride administration
, 2020; 13(2): 159-163.Viviana Frantellizzi*, Mariano Pontico, Arianna Pani, Roberto Pani and Giuseppe De Vincentis
DOI: 10.2174/1874471012666190927115331
Research Article
Preparation and biological evaluation of<sup>67</sup> gallium-labeled iranian hemiscorpius lepturus scorpion venom
, 2020; 13(2): 99-106.Amir Jalali*, Mona Haddad Zahmatkesh, Amir Reza Jalilian, Amir Taheri Borujeni and Behrouz Alirezapour
DOI: 10.2174/1874471012666190828155227
Most Accessed Articles
PET/CT and the Response to Immunotherapy in Lung Cancer
, 2020; 13(3): 177-184.Laura Evangelista*, Matteo Sepulcri and Giulia Pasello
DOI: 10.2174/1874471013666191220105449
Analysis of Cell Fraction of 99mTc-HMPAO Radiolabeled Leukocytes
, 2020; 13(2): 142-148.Eun-Mi Kim, Hwan-Jeong Jeong*, Seok-Tae Lim and Myung-Hee Sohn
DOI: 10.2174/1874471013666200510015742
Respiratory Gating and the Performance of PET/CT in Pulmonary Lesions
, 2020; 13(3): 218-227.Cinzia Crivellaro and Luca Guerra*
DOI: 10.2174/1874471013666200317144629
Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas
, 2020; 13(2): 94-98.Francesco Bertagna*, Domenico Albano, Elisabetta Cerudelli, Maria Gazzilli, Raffaele Giubbini and Giorgio Treglia
DOI: 10.2174/1874471012666191017093721
In situ Generated 212Pb-PSMA Ligand in a 224Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells
, 2020; 13(2): 130-141.Vilde Y. Stenberg, Asta Juzeniene*, Øyvind S. Bruland and Roy H. Larsen
DOI: 10.2174/1874471013666200511000532
Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications
, 2020; 13(1): 63-79.Sara Pastorino, Mattia Riondato, Licia Uccelli, Giampiero Giovacchini, Elisabetta Giovannini, Valerio Duce and Andrea Ciarmiello*
DOI: 10.2174/1874471012666190729151540
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art
, 2020; 13(3): 228-237.Angelo Castello , Sabrina Rossi and Egesta Lopci *
DOI: 10.2174/1874471013666191230144821
Oxidant and Antioxidant Effects of Gentisic Acid in a 177Lu-Labelled Methionine-Containing Minigastrin Analogue
, 2020; 13(2): 107-119.Victoria Trindade* and Henia Balter
DOI: 10.2174/1874471012666190916112904
The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy
, 2020; 13(3): 243-248.Marco Spadafora*, Laura Evangelista, Salvatore Fiordoro, Francesco Porcaro, Marilena Sicignano and Luigi Mansi
DOI: 10.2174/1874471013666200318142210
Lung Cancer and Radiological Imaging
, 2020; 13(3): 238-242.Annalori Panunzio* and Paolo Sartori
DOI: 10.2174/1874471013666200523161849
Analysis of Unusual Adverse Effects After Radium-223 Dichloride Administration
, 2020; 13(2): 159-163.Viviana Frantellizzi*, Mariano Pontico, Arianna Pani, Roberto Pani and Giuseppe De Vincentis
DOI: 10.2174/1874471012666190927115331
Evidence-Based Data About Prevalence and Risk of Malignancy of Thyroid Incidentalomas Detected by Different PET Radiopharmaceuticals
, 2020; 13(2): 89-93.Giovanni Signore, Domenico Albano, Luca Giovanella, Francesco Bertagna and Giorgio Treglia*
DOI: 10.2174/1874471012666191212115732
99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
, 2020; 13(3): 166-176.Vittorio Briganti, Vincenzo Cuccurullo*, Valentina Berti, Giuseppe D. Di Stasio, Flavia Linguanti, Francesco Mungai and Luigi Mansi
DOI: 10.2174/1874471013666191230143610
Alternative and New Radiopharmaceutical Agents for Lung Cancer
, 2020; 13(3): 185-194.Silvi Telo*, Letizia Calderoni, Sara Vichi, Federico Zagni, Paolo Castellucci and Stefano Fanti
DOI: 10.2174/1874471013666191223151402
Radiotherapy Planning and Molecular Imaging in Lung Cancer
, 2020; 13(3): 204-217.Angelina Filice*, Massimiliano Casali, Patrizia Ciammella, Marco Galaverni, Federica Fioroni, Cinzia Iotti and Annibale Versari
DOI: 10.2174/1874471013666200318144154
Editor-in-Chief
Sean L. Kitson
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
(Northern Ireland)
Biography
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
Biography
Biography of Sean L. Kitson
Dr Kitson is an Investigator of Radiochemistry at Almac, UK. He has over 15 years of experience in the synthesis of carbon-14 labelled compounds. Dr Kitson is the Editor-in-Chief of Current Radiopharmaceuticals published by Bentham Science Publishers and the Journal of Diagnostic Imaging in Therapy. He has published over 45 research, reviews and commercial articles in the area of carbon-14 synthesis and medical imaging. His contribution to radiochemistry was acknowledged by winning the 2006 Wiley Journal of Labelled Compounds and Radiopharmaceuticals Young Scientists Award. Since, 2007 he has been a Member of the Scientific Committee for the International Isotopes Society (IIS) UK group.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Radiopharmaceuticals Journal was launched in 2008. Dr. Sean L. Kitson serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.77
Webmaster Contact: info@benthamscience.net